2024-11-012025-10-312025-10-31false10056283V & V CARE LIMITED2026-10-31falseiso4217:GBPxbrli:pure100562832024-10-31100562832025-10-31100562832024-11-012025-10-31100562832023-10-31100562832024-10-31100562832023-11-012024-10-3110056283bus:SmallEntities2024-11-012025-10-3110056283bus:AuditExempt-NoAccountantsReport2024-11-012025-10-3110056283bus:AbridgedAccounts2024-11-012025-10-3110056283bus:PrivateLimitedCompanyLtd2024-11-012025-10-3110056283core:WithinOneYear2025-10-3110056283core:AfterOneYear2025-10-3110056283core:WithinOneYear2024-10-3110056283core:AfterOneYear2024-10-3110056283core:ShareCapital2025-10-3110056283core:SharePremium2025-10-3110056283core:RevaluationReserve2025-10-3110056283core:OtherReservesSubtotal2025-10-3110056283core:RetainedEarningsAccumulatedLosses2025-10-3110056283core:ShareCapital2024-10-3110056283core:SharePremium2024-10-3110056283core:RevaluationReserve2024-10-3110056283core:OtherReservesSubtotal2024-10-3110056283core:RetainedEarningsAccumulatedLosses2024-10-3110056283core:LandBuildings2025-10-3110056283core:PlantMachinery2025-10-3110056283core:Vehicles2025-10-3110056283core:FurnitureFittings2025-10-3110056283core:OfficeEquipment2025-10-3110056283core:NetGoodwill2025-10-3110056283core:IntangibleAssetsOtherThanGoodwill2025-10-3110056283core:ListedExchangeTraded2025-10-3110056283core:UnlistedNon-exchangeTraded2025-10-3110056283core:LandBuildings2024-10-3110056283core:PlantMachinery2024-10-3110056283core:Vehicles2024-10-3110056283core:FurnitureFittings2024-10-3110056283core:OfficeEquipment2024-10-3110056283core:NetGoodwill2024-10-3110056283core:IntangibleAssetsOtherThanGoodwill2024-10-3110056283core:ListedExchangeTraded2024-10-3110056283core:UnlistedNon-exchangeTraded2024-10-3110056283core:LandBuildings2024-11-012025-10-3110056283core:PlantMachinery2024-11-012025-10-3110056283core:Vehicles2024-11-012025-10-3110056283core:FurnitureFittings2024-11-012025-10-3110056283core:OfficeEquipment2024-11-012025-10-3110056283core:NetGoodwill2024-11-012025-10-3110056283core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3110056283core:ListedExchangeTraded2024-11-012025-10-3110056283core:UnlistedNon-exchangeTraded2024-11-012025-10-3110056283core:MoreThanFiveYears2024-11-012025-10-3110056283core:Non-currentFinancialInstruments2025-10-3110056283core:Non-currentFinancialInstruments2024-10-3110056283dpl:CostSales2024-11-012025-10-3110056283dpl:DistributionCosts2024-11-012025-10-3110056283core:LandBuildings2024-11-012025-10-3110056283core:PlantMachinery2024-11-012025-10-3110056283core:Vehicles2024-11-012025-10-3110056283core:FurnitureFittings2024-11-012025-10-3110056283core:OfficeEquipment2024-11-012025-10-3110056283dpl:AdministrativeExpenses2024-11-012025-10-3110056283core:NetGoodwill2024-11-012025-10-3110056283core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3110056283dpl:GroupUndertakings2024-11-012025-10-3110056283dpl:ParticipatingInterests2024-11-012025-10-3110056283dpl:GroupUndertakingscore:ListedExchangeTraded2024-11-012025-10-3110056283core:ListedExchangeTraded2024-11-012025-10-3110056283dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-11-012025-10-3110056283core:UnlistedNon-exchangeTraded2024-11-012025-10-3110056283dpl:CostSales2023-11-012024-10-3110056283dpl:DistributionCosts2023-11-012024-10-3110056283core:LandBuildings2023-11-012024-10-3110056283core:PlantMachinery2023-11-012024-10-3110056283core:Vehicles2023-11-012024-10-3110056283core:FurnitureFittings2023-11-012024-10-3110056283core:OfficeEquipment2023-11-012024-10-3110056283dpl:AdministrativeExpenses2023-11-012024-10-3110056283core:NetGoodwill2023-11-012024-10-3110056283core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3110056283dpl:GroupUndertakings2023-11-012024-10-3110056283dpl:ParticipatingInterests2023-11-012024-10-3110056283dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-012024-10-3110056283core:ListedExchangeTraded2023-11-012024-10-3110056283dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-012024-10-3110056283core:UnlistedNon-exchangeTraded2023-11-012024-10-3110056283core:NetGoodwill2025-10-3110056283core:IntangibleAssetsOtherThanGoodwill2025-10-3110056283core:LandBuildings2025-10-3110056283core:PlantMachinery2025-10-3110056283core:Vehicles2025-10-3110056283core:FurnitureFittings2025-10-3110056283core:OfficeEquipment2025-10-3110056283core:AfterOneYear2025-10-3110056283core:WithinOneYear2025-10-3110056283core:ListedExchangeTraded2025-10-3110056283core:UnlistedNon-exchangeTraded2025-10-3110056283core:ShareCapital2025-10-3110056283core:SharePremium2025-10-3110056283core:RevaluationReserve2025-10-3110056283core:OtherReservesSubtotal2025-10-3110056283core:RetainedEarningsAccumulatedLosses2025-10-3110056283core:NetGoodwill2024-10-3110056283core:IntangibleAssetsOtherThanGoodwill2024-10-3110056283core:LandBuildings2024-10-3110056283core:PlantMachinery2024-10-3110056283core:Vehicles2024-10-3110056283core:FurnitureFittings2024-10-3110056283core:OfficeEquipment2024-10-3110056283core:AfterOneYear2024-10-3110056283core:WithinOneYear2024-10-3110056283core:ListedExchangeTraded2024-10-3110056283core:UnlistedNon-exchangeTraded2024-10-3110056283core:ShareCapital2024-10-3110056283core:SharePremium2024-10-3110056283core:RevaluationReserve2024-10-3110056283core:OtherReservesSubtotal2024-10-3110056283core:RetainedEarningsAccumulatedLosses2024-10-3110056283core:NetGoodwill2023-10-3110056283core:IntangibleAssetsOtherThanGoodwill2023-10-3110056283core:LandBuildings2023-10-3110056283core:PlantMachinery2023-10-3110056283core:Vehicles2023-10-3110056283core:FurnitureFittings2023-10-3110056283core:OfficeEquipment2023-10-3110056283core:AfterOneYear2023-10-3110056283core:WithinOneYear2023-10-3110056283core:ListedExchangeTraded2023-10-3110056283core:UnlistedNon-exchangeTraded2023-10-3110056283core:ShareCapital2023-10-3110056283core:SharePremium2023-10-3110056283core:RevaluationReserve2023-10-3110056283core:OtherReservesSubtotal2023-10-3110056283core:RetainedEarningsAccumulatedLosses2023-10-3110056283core:AfterOneYear2024-11-012025-10-3110056283core:WithinOneYear2024-11-012025-10-3110056283core:Non-currentFinancialInstrumentscore:CostValuation2024-11-012025-10-3110056283core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-012025-10-3110056283core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-012025-10-3110056283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-012025-10-3110056283core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-012025-10-3110056283core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-012025-10-3110056283core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3110056283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3110056283core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3110056283core:Non-currentFinancialInstrumentscore:CostValuation2025-10-3110056283core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-10-3110056283core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-10-3110056283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-10-3110056283core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-10-3110056283core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-10-3110056283core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-10-3110056283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-10-3110056283core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-10-3110056283core:Non-currentFinancialInstrumentscore:CostValuation2024-10-3110056283core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-3110056283core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-3110056283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-3110056283core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-3110056283core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-3110056283core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-3110056283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-3110056283core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-3110056283bus:Director12024-11-012025-10-3110056283bus:Director22024-11-012025-10-3110056283bus:Director32024-11-012025-10-3110056283bus:Director42024-11-012025-10-31

V & V CARE LIMITED

Registered Number
10056283
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2025

V & V CARE LIMITED
Company Information
for the year from 1 November 2024 to 31 October 2025

Directors

RAJENDRA, Sivadasan
RAJENDRA, Vaani
RAJENDRA, Vishali
SIVADASAN, Shanthi

Registered Address

2 Perne Avenue
Cambridge
CB1 3SA

Registered Number

10056283 (England and Wales)
V & V CARE LIMITED
Balance Sheet as at
31 October 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets3130,350142,200
Tangible assets4524,188524,196
Investments(415,490)(423,490)
239,048242,906
Current assets
Debtors8,8504,850
Cash at bank and on hand164,57682,174
173,42687,024
Creditors amounts falling due within one year5(309,751)(171,656)
Net current assets (liabilities)(136,325)(84,632)
Total assets less current liabilities102,723158,274
Creditors amounts falling due after one year6(287,627)(323,856)
Net assets(184,904)(165,582)
Capital and reserves
Called up share capital100100
Profit and loss account(185,004)(165,682)
Shareholders' funds(184,904)(165,582)
The financial statements were approved and authorised for issue by the Board of Directors on 31 October 2026, and are signed on its behalf by:
SIVADASAN, Shanthi
Director
Registered Company No. 10056283
V & V CARE LIMITED
Notes to the Financial Statements
for the year ended 31 October 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Dividend income
Dividend income is recognised when the right to receive payment is established.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20252024
Average number of employees during the year2017
3.Intangible assets

Total

£
Cost or valuation
At 01 November 24237,000
At 31 October 25237,000
Amortisation and impairment
At 01 November 2494,800
Charge for year11,850
At 31 October 25106,650
Net book value
At 31 October 25130,350
At 31 October 24142,200
4.Tangible fixed assets

Total

£
Cost or valuation
At 01 November 24549,319
At 31 October 25549,319
Depreciation and impairment
At 01 November 2425,124
Charge for year7
At 31 October 2525,131
Net book value
At 31 October 25524,188
At 31 October 24524,196
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables15,21615,216
Bank borrowings and overdrafts8,9248,839
Amounts owed to related parties201,49132,045
Taxation and social security80,729109,617
Other creditors2,3414,642
Accrued liabilities and deferred income1,0501,297
Total309,751171,656
Creditors amount falling due in one year £272,839
6.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts287,627323,856
Total287,627323,856
Creditors: amounts falling due after more than one year £287,627
7.Share capital
45 A Ordinary , 45 B Ordinary, 5 C Ordinary, 5 D Ordinary